ZYLACTA

Zylacta Corporation is an early stage biotech company based in Gaithersburg, Maryland, focused on the discovery and development of peptidoglycan-based products for immunotherapy. We offer proven methods to develop these hits into drugs via a gene-based technology that is rooted in our expertice in genomics of bacterial peptidoglycan synthesis, maturation and "shedding"... We discovered that certain peptidoglycan fragments represent important new classes of potential drugs, which Zylacta is uniquely positioned to develop. These compounds interact with essential elements of innate immunity and demonstrate high potential in the treatment of socially important diseases... Zylacta is committed to changing our perception of microbes. Instead of declaring war on germs, we need to think of them in the context of ecosystems that make up our bodies and as a natural source of energy and medicinal compounds that humans can't make on their own. Zylacta is developing a defined portfolio of its own..

Also known as: Zylacta Corporation

Primary location: Gaithersburg United States